Spectrum Pharmaceuticals Inc

GOLDMAN SACHS GROUP INC

Report date

6/30/2023

Quarter

2023 Q2

Filed

5/14/2024

Shares

19,106

Value ($000)

18

Weight

0.0%

2013 Q4 - 2023 Q2 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	5/14/2024	18	0.0%	19,106	6/30/2023
2023 Q1	5/14/2024	15	0.0%	19,426	3/31/2023
2022 Q4	5/14/2024	5	0.0%	12,931	12/31/2022
2022 Q3	5/14/2024	37	0.0%	84,825	9/30/2022
2022 Q2	5/14/2024	215	0.0%	276,163	6/30/2022
2022 Q1	5/16/2022	320	0.0%	248,071	3/31/2022
2021 Q4	2/17/2022	3,705	0.0%	2,916,719	12/31/2021
2021 Q3	1/20/2022	868	0.0%	398,432	9/30/2021
2021 Q2	8/13/2021	1,476	0.0%	393,644	6/30/2021
2021 Q1	5/17/2021	1,405	0.0%	431,090	3/31/2021
2020 Q4	2/12/2021	2,445	0.0%	717,003	12/31/2020
2020 Q3	11/13/2020	2,964	0.0%	726,445	9/30/2020
2020 Q2	8/12/2020	2,874	0.0%	850,303	6/30/2020
2020 Q1	5/15/2020	2,580	0.0%	1,107,340	3/31/2020
2019 Q4	2/14/2020	2,601	0.0%	714,721	12/31/2019
2014 Q1	5/15/2014	10,864	0.0%	1,385,773	3/31/2014
2013 Q4	2/14/2014	11,749	0.0%	1,327,560	12/31/2013